There is an urgent need for new therapies against and control of infectious diseases. Silver nanoparticles are considered a potential source of novel antimicrobial agents, since it offers several advantages such as broad-spectrum activity and lower tendency to induce resistance.
This motivated Prebona to successfully develop an entirely new form of silver, Prebona AgSol, which is a composed of a controlled amount of silver ions strongly attached to a silica carrier particle. It can combat various kinds of micro organisms using hundred or thousand of times less silver compared to competing technologies. Prebona can design the compound on an atomic level with desired number of silver ions per silica particle and exact size control of the carrier particle, which will allow for the most effective solutions.
Areas of interest
Prebona offer the health sector a toolbox of possibilities to help reduce healthcare-associated infections (HAI) in a safe and responsible way. The truly unique possibilities create a powerful protection against HAI from the operating room to the patient rooms. Solutions are available for surface coating on walls and ceilings. Protect textiles on furniture, screens and curtains. Keep your medical devices protected. We have solutions to reduce bacteria prevalence in hospital water and air systems, such as heating- and drinking water systems and air ventilation systems. Prebona provides tools you need to reduce risk of infection in hospital environment.
Silver dressings are commonly used in the treatment of burns and chronic wounds. The active agent, silver ions, is an effective broad-spectrum antimicrobial agent whilst remaining non-toxic to human tissue. Prebona provides a sustainable and powerful antimicrobial barrier for any dressing using hundred of times less silver compared to competing technologies.
Silver Nanoparticles are active on a broad range of viruses and bacteria. It presents lower risk for resistance development compared to conventional treatments. This makes silver a good candidate for new therapies against virus and bacteria induced illnesses. Prebona has initiated a pharmaceutical development program against common viral diseases using the unique possibilities to modify and tailor make an antiviral agent. The company works together with experts at leading clinical universities.
(Note that some products are not sold in all territories):